TABLE 1.

Patient characteristics and CL_CR measurements for fluconazole

Patient no.a	Genderb	Age (yr)	Height (cm)	Weight (kg)	% of TBSA:			Day of hospitalization on which therapy was initiated	CLCR (ml/min)
					Burned	With third-degree burns	With second-degree burns		Day 3	Day 8
1	M	30	175	70	90	90	0	2	161	102
2	M	27	193	95	95	5	90	2	169	NDc
3	F	65	160	68	35	25	10	2	60	ND
4	M	30	175	79	42	0	42	2	127	155
6	M	32	173	84	48	8	40	2	137	128
7	M	52	178	92	30	0	30	1	ND	ND
8	M	24	83	73	38	38	0	2	190	156
9	F	45	165	61	40	15	25	1	106	ND
10	M	61	183	97	38	7	31	2	119	ND
Mean ± SD		40 ± 15	165 ± 32	80 ± 12	50 ± 24	21 ± 29	30 ± 28		133 ± 41	135 ± 26

^aPatient 5 was excluded from study due to hemodynamic instability. 

^bM, male; F, female. 

^cND, no data (due to sample mishandling).